Cellulose supplementation early in life ameliorates colitis in adult mice

PLoS One. 2013;8(2):e56685. doi: 10.1371/journal.pone.0056685. Epub 2013 Feb 20.

Abstract

Decreased consumption of dietary fibers, such as cellulose, has been proposed to promote the emergence of inflammatory bowel diseases (IBD: Crohn disease [CD] and ulcerative colitis [UC]) where intestinal microbes are recognized to play an etiologic role. However, it is not known if transient fiber consumption during critical developmental periods may prevent consecutive intestinal inflammation. The incidence of IBD peaks in young adulthood indicating that pediatric environmental exposures may be important in the etiology of this disease group. We studied the effects of transient dietary cellulose supplementation on dextran sulfate sodium (DSS) colitis susceptibility during the pediatric period in mice. Cellulose supplementation stimulated substantial shifts in the colonic mucosal microbiome. Several bacterial taxa decreased in relative abundance (e.g., Coriobacteriaceae [p = 0.001]), and other taxa increased in abundance (e.g., Peptostreptococcaceae [p = 0.008] and Clostridiaceae [p = 0.048]). Some of these shifts persisted for 10 days following the cessation of cellulose supplementation. The changes in the gut microbiome were associated with transient trophic and anticolitic effects 10 days following the cessation of a cellulose-enriched diet, but these changes diminished by 40 days following reversal to a low cellulose diet. These findings emphasize the transient protective effect of dietary cellulose in the mammalian large bowel and highlight the potential role of dietary fibers in amelioration of intestinal inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cellulose / administration & dosage*
  • Colitis / chemically induced
  • Colitis / diet therapy*
  • Colitis / prevention & control
  • Colitis, Ulcerative / diet therapy*
  • Colitis, Ulcerative / pathology
  • Crohn Disease / diet therapy*
  • Crohn Disease / pathology
  • Dextran Sulfate / toxicity
  • Dietary Fiber / administration & dosage
  • Dietary Supplements
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / microbiology
  • Metagenome
  • Mice

Substances

  • Dietary Fiber
  • Cellulose
  • Dextran Sulfate

Grants and funding

This work was supported in part by the Broad Medical Research Program, the Broad Foundation (IBD-0252); the Child Health Research Career Development Agency of the Baylor College of Medicine; the Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA Ref #2426); the United States Department of Agriculture 6250-51000-046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.